Genital herpes is common, and for many people the more practical question isn't how to treat a single outbreak, it's how to manage a condition that can recur over months or years. Suppressive therapy is one of two main medication strategies clinicians discuss for that longer view, and it works differently from treating an outbreak as it happens.
This is patient education, not medical advice. Only an independent licensed medical professional can decide whether suppressive therapy, or any treatment, is appropriate for you, after a proper evaluation.
What suppressive therapy means
Suppressive therapy refers to taking an antiviral medication on a consistent daily schedule, rather than only starting treatment once symptoms appear. Valacyclovir, taken by mouth, is FDA-approved for suppressive therapy of recurrent genital herpes in adults with normal immune function, and it is the antiviral most often discussed for this purpose because of its convenient once-daily dosing.
The alternative approach, episodic therapy, treats an outbreak after it starts, usually with a short course of the same class of medication taken at the first sign of symptoms. Suppressive therapy is a different strategy aimed at reducing how often those outbreaks happen in the first place, rather than shortening each one after the fact.
Suppressive therapy isn't automatically the right fit for everyone with genital herpes. People with occasional, infrequent recurrences may find episodic treatment, used only when needed, perfectly manageable. Suppressive therapy tends to come up in conversation when outbreaks recur often enough, or affect daily life and relationships enough, that a daily medication starts to look like the more practical option.
Before suppressive therapy is ever considered, a clinician generally confirms the diagnosis, which usually involves an in-person clinical evaluation and, when an outbreak is active, testing a sample from a lesion, along with a discussion of symptom history. This isn't a step to skip: other conditions can mimic genital herpes, and the specific antiviral strategy that makes sense depends on having a clear diagnosis to plan around in the first place.
How daily antiviral therapy works
Valacyclovir is a prodrug, meaning the body converts it into acyclovir after it's absorbed. Acyclovir is a nucleoside analog that interferes with the way the herpes virus copies its own DNA, which is how it limits viral replication during an active outbreak and, with daily dosing, helps keep reactivation in check between them.
Because suppressive therapy keeps a steady level of the medication in the body, it doesn't depend on catching the first signs of an outbreak the way episodic treatment does. That's the core practical difference: episodic therapy only works well when it's started promptly, which means recognizing early symptoms and having medication on hand, while suppressive therapy removes most of that timing pressure by treating continuously.
Other antivirals in the same general family, including acyclovir and famciclovir, are also used for herpes management, but valacyclovir's dosing schedule is a common reason clinicians favor it for suppressive use specifically. The choice of which antiviral, and which strategy, is still an individual clinical decision.
Suppressive therapy is generally intended to be continued for as long as it remains appropriate, which for many people means an extended period rather than a short course. A clinician will periodically revisit whether it still fits, since outbreak patterns can change over time, and stopping or pausing suppressive therapy is itself a decision worth discussing rather than something to do abruptly on your own.
Suppressive therapy vs episodic, as-needed treatment
Choosing between the two approaches usually comes down to a handful of practical questions: how often outbreaks recur, how disruptive or distressing they are, whether a partner is involved, and how someone feels about taking a daily medication versus keeping one on hand for occasional use.
Episodic therapy can work well for people whose outbreaks are infrequent and who reliably notice early warning symptoms, since starting treatment promptly at the first sign matters for how effective it is. Suppressive therapy tends to be considered when recurrences happen often enough that episodic dosing starts to feel like a constant, unpredictable interruption, or when someone simply prefers the consistency of a daily routine over reacting to each outbreak individually.
Neither approach is inherently better; they solve slightly different problems. A licensed clinician weighs outbreak frequency and pattern, overall health, and personal preference to help decide which strategy, or whether a period of one followed by a switch to the other, makes sense for a given person.
The core distinction
Episodic therapy treats an outbreak after it starts. Suppressive therapy is taken every day, whether or not symptoms are present, with the goal of reducing how often outbreaks occur in the first place.
Suppressive therapy and reducing transmission risk
Beyond reducing outbreak frequency, suppressive therapy is also discussed in the context of transmission. FDA-approved labeling for valacyclovir describes evidence, from studies in heterosexual couples where one partner had recurrent genital herpes and the other did not, that daily suppressive therapy combined with safer sex practices can help reduce the risk of transmitting the virus to a partner.
It's important to be precise about what that means: suppressive therapy can lower transmission risk in the circumstances it has been studied in, it does not eliminate that risk. The virus can still be present, and potentially transmissible, even without visible symptoms, a phenomenon called asymptomatic shedding. Consistent condom use, open communication with a partner, and regular STI testing remain part of a complete risk-reduction approach rather than something suppressive therapy replaces on its own.
It's also worth noting that valacyclovir suppressive therapy addresses genital herpes specifically. It doesn't provide protection against other sexually transmitted infections, which is one reason our explainers on PrEP for HIV prevention and DoxyPEP for STI prevention cover different, complementary prevention strategies rather than substitutes for one another.
Safety considerations and monitoring
Valacyclovir is generally well tolerated when used as prescribed. The most commonly reported side effects include headache, nausea, and abdominal discomfort, and these are often mild. Because the medication is cleared through the kidneys, dosing needs to be adjusted for people with reduced kidney function, which is one of the things a clinician checks before prescribing long-term suppressive therapy.
Rare but serious reactions, including a blood disorder called thrombotic thrombocytopenic purpura or hemolytic uremic syndrome, have been reported at high doses, primarily in people with advanced HIV infection or in transplant recipients receiving other immunosuppressive treatment. This underscores why suppressive therapy is a prescription decision made after reviewing someone's full health history, not something to start or continue without clinical oversight.
Because suppressive therapy is typically taken on an ongoing basis, periodic follow-up matters, both to confirm the medication is still doing its job and to revisit whether daily treatment continues to be the right fit as circumstances change, including pregnancy, changes in kidney function, or a shift in outbreak pattern over time.
Talking to a clinician about suppressive therapy
If frequent or disruptive genital herpes outbreaks are affecting your daily life or a relationship, the productive next step is a conversation with a licensed clinician rather than self-managing with over-the-counter products. A clinician can review your outbreak history, discuss what you're hoping to achieve, and explain whether suppressive therapy, episodic treatment, or another approach fits your situation. Starting a consultation does not guarantee that valacyclovir or any other treatment will be prescribed.
Questions worth bringing to that conversation include:
- How often outbreaks recur and how much they affect your daily life or relationships.
- Your partner status and any transmission concerns you want to discuss.
- Your kidney function and other health conditions, since these affect dosing and safety.
- Whether you'd prefer a daily routine or an as-needed approach, since both are legitimate options depending on your circumstances.
A clinician may also suggest starting with one approach and revisiting it later; that flexibility is a normal part of managing a recurring condition, not a sign that the first plan failed.
The bottom line
Suppressive therapy means taking an antiviral medication like valacyclovir every day to reduce how often genital herpes outbreaks occur, and it may also help lower, without eliminating, the risk of transmitting the virus to a partner. It doesn't cure herpes, and it's a different strategy from episodic, as-needed treatment. Which approach makes sense depends on outbreak frequency, personal preference, and overall health, and that's a decision made with a licensed clinician after an evaluation. You can explore related explainers in our Sexual Health category, including DoxyPEP for STI prevention and PrEP for HIV prevention, and read about our editorial standards on the About the Journal page.
Important Safety Information
Indication. Valacyclovir is an antiviral medication FDA-approved for the treatment of genital herpes, including suppressive therapy to reduce the frequency of recurrent outbreaks in people with normal immune function, and, in specific studied circumstances alongside safer sex practices, to help reduce the risk of transmitting genital herpes to a heterosexual partner.
Common side effects. Headache, nausea, abdominal pain, and vomiting are among the most commonly reported side effects. Side effects vary by individual.
Warnings. Dose adjustment is required for people with reduced kidney function. Rare but serious reactions, including thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, have been reported at high doses, primarily in people with advanced HIV infection or transplant recipients. Tell your clinician about your kidney function, immune status, and all current medications.
Talk to your doctor. This information is educational and is not a substitute for medical advice. Only a licensed medical professional can determine whether a treatment is right for you. Talk to your doctor about the benefits and risks, and report any side effects.
Frequently asked questions
What is suppressive therapy for genital herpes?
Suppressive therapy means taking an antiviral medication, most often valacyclovir, on a daily schedule rather than only when symptoms appear. The goal is to reduce how often outbreaks occur. It differs from episodic therapy, which treats a single outbreak after it starts.
Does suppressive therapy cure genital herpes?
No. Genital herpes is caused by a virus that remains in the body indefinitely between outbreaks, and no available treatment removes it. Suppressive therapy reduces how often outbreaks happen and may lower transmission risk, but it does not cure the underlying infection.
Can suppressive therapy lower the risk of passing herpes to a partner?
FDA-approved labeling for valacyclovir describes evidence that daily suppressive therapy can help reduce the risk of transmitting genital herpes to a partner in specific studied circumstances. It does not eliminate that risk, and steps such as consistent condom use and disclosure still matter.
Who might consider suppressive therapy instead of episodic treatment?
People with frequent recurrences, a partner who does not have herpes, or outbreaks that meaningfully affect daily life or relationships often discuss suppressive therapy with a clinician. The right approach depends on outbreak pattern, personal preference, and other health factors, and is decided individually.
What are the main safety considerations with suppressive antiviral therapy?
Valacyclovir is generally well tolerated, with headache and nausea among the more commonly reported side effects. Dose adjustment is needed for reduced kidney function, and rare serious reactions have been reported at high doses in people who are immunocompromised. A clinician reviews your health history before prescribing.
